Morton, Ronald L |
NCT05641298: Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations |
|
|
| Withdrawn | 2 | 80 | US | Sodium Fusidate, ACG-701, ARV-1801, Placebo | Aceragen | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 09/23 | 09/23 | | |
NCT06052293: Phase 1 Study to Assess Safety and Efficacy of ANG003 |
|
|
| Completed | 1 | 51 | US | ANG003, Dose Level 1, Dose Level 2, Dose Level 3, and Dose Level 4. | Anagram Therapeutics, Inc. | Exocrine Pancreatic Insufficiency | 07/24 | 07/24 | | |
Harper, Molly |
| Active, not recruiting | N/A | 150 | US | Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device | Abbott Medical Devices | Atrial Fibrillation Paroxysmal, Atrial Fibrillation, Persistent, Cardiac Arrhythmia, Ablation | 12/24 | 12/25 | | |
| Enrolling by invitation | N/A | 583 | US | | Boston Scientific Corporation | Paroxysmal Atrial Fibrillation | 07/25 | 10/25 | | |
| Recruiting | N/A | 475 | Europe, Canada, US | Amuletâ„¢ 2 Left Atrial Appendage (LAA) Occluder | Abbott Medical Devices | Atrial Fibrillation (AF), Stoke | 07/26 | 07/28 | | |
NCT05988411: ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation Vs Control in Redo Ablation Patients |
|
|
| Recruiting | N/A | 250 | US | Renal Denervation, Catheter Ablation | Vivek Reddy | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | 12/27 | 12/27 | | |